PfizerPharmaceutical Companies

ATIVESITE | Pfizer needs to ‘fix what they have’, no M&A capacity, says BMO’s Evan Seigerman on activist stake



Evan David Seigerman, BMO Biotech Analyst, joins ‘Closing Bell Overtime’ to talk Pfizer shares climbing on activist firm Starboard taking a stake in the company.

Source Pfizer YouTube

 

1111

ativesite

Health First, Well-Being Always!